Ionis Pharmaceuticals Inc
(MEX:IONS)
MXN
1,150
(0%)
Market Cap: 229.56 Bil
Enterprise Value: 231.70 Bil
PE Ratio: 0
PB Ratio: 26.77
GF Score: 65/100 Ionis Pharmaceuticals Inc at Stifel Virtual CNS Forum Transcript
Mar 17, 2026 / 03:00PM GMT
Release Date Price:
MXN1150
Paul Matteis
Stifel Nicolaus & Company Inc - Equity Analyst
Great, thanks very much, everybody. It's my pleasure to be here with Holly Kordasiewicz to talk about the Ionis neuroscience pipeline.
Questions & Answers
Paul Matteis
Stifel Nicolaus & Company Inc - Equity Analyst
Holly, instead of asking you to just give like some prepared remarks, do you mind if we just like get right into it? Is that cool?
Holly Kordasiewicz
Ionis Pharmaceuticals Inc - Executive Vice President and Chief Development Officer
Sure.
Paul Matteis
Stifel Nicolaus & Company Inc - Equity Analyst
Okay, all right, sweet, thank you. Okay, so I am like super excited for this tow readout coming up later this year.
But I think, one of the things that's hard to really answer in research about tau is the whole correlation causation question, which was a question with amyloid for a long time. Obviously, the correlation piece was like somewhat disproven.
But as it
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot